Imperial College London Diabetes Centre (ICLDC), part of Mubadala’s network of healthcare providers, and Abu Dhabi’s one-stop-shop for the treatment, prevention, education and research of diabetes, has partnered with its sister facility, Healthpoint, a multi-speciality hospital in Abu Dhabi, to establish a newly integrated thyroid clinic. This collaboration will enable patients to have their thyroid related problems managed in a combined multidisciplinary setting.
The joint clinic, to be located at ICLDC’s Zayed Sports City branch in Abu Dhabi, will use the combined expertise of Mubadala’s healthcare entities to offer an integrated approach to thyroid care. Specialist services will include consultation, testing, diagnosis, risk estimation and surgery, addressing a variety of thyroid-related conditions, such as nodules, goitres, Graves’ disease, thyroid cancer and parathyroid adenoma.
The clinic will be equipped to perform a wide range of procedures, such as thyroid examination, non-invasive ultrasonography, ultrasound-guided fine-needle aspiration (FNA), thyroid nodule ablation (with sclerosing agent or thermal ablation), and various types of surgery including partial and total thyroidectomy as well as parathyroidectomy.
The expert team will comprise specialist thyroid surgeon Dr. Luaay Aziz from Healthpoint in addition to a trio of endocrinologists from ICLDC – Dr. Aly Bernard Khalil, Dr. Ali Bakir and Dr. Safdar Naqvi.
Suhail Mahmood Al Ansari, Chairman of Healthpoint and Imperial College London Diabetes Centre, and Executive Director of Mubadala Healthcare said: “The partnership between ICLDC and Healthpoint is set to greatly enhance Mubadala’s healthcare offering. We are committed to best practice, and our latest venture aligns with our mandate of promoting medical excellence, providing the highest quality of care, and facilitating clinical collaboration and knowledge transfer.”
He added: “In bringing our best medical specialists together under one roof to offer thyroid patients peace of mind, we are confident the new clinic’s expertise in this specific area of medicine will go a long way towards elevating the standards of thyroid care in the region.”
The World Health Organization estimates that around 750 million people globally have a thyroid malfunction, with women up to eight times more likely to experience disorders. According to statistics from the 10th Annual Middle East Otolaryngology Conference and Exhibition that took place in Dubai in April 2017, around five per cent of the UAE population suffers from various thyroid conditions.
About Imperial College London Diabetes Centre
Imperial College London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility that specialises in diabetes treatment, research, training and public health awareness.
The Centre was established in Abu Dhabi by Mubadala Healthcare, in partnership with the UK’s Imperial College London, in 2006 to address the growing demand for diabetes care in the UAE. A second facility in Al Ain opened in 2011. Together, the Centres have offered diabetes prevention, education and treatment to more than 800,000 patient contacts.
‘Diabetes.Knowledge.Action’ is the Imperial College London Diabetes Centre’s award-winning public health awareness campaign. It was launched in 2007 under the patronage of Her Highness Sheikha Fatima bint Mubarak.
Imperial College London Diabetes Centre holds the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) in Diabetes Management and JCI Accreditation for Ambulatory Care, awarded in 2010 and again in 2013. The 2010 award made Imperial College London Diabetes Centre the only healthcare provider worldwide to hold both certifications and the first facility in the Middle East and third globally to hold JCI’s highly-acclaimed CCPC specifically for the clinical management of diabetes.
For more information log on to www.icldc.ae